Organization
Sandoz, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sandoz, Inc.
... representing drug maker Alvogen. "Yes," Fox said. Alvogen, Hikma Pharmaceuticals USA and Sandoz Inc. are suing to stop the use of their products in Nevada's ...
... announces the signing of a definitive agreement to acquire certain assets from Sandoz Inc., USA ('Sandoz'), a Novartis Division, comprising a market leading dermatology business ...
... Mylan have very different businesses than the largely commodity and dermatology portfolio Sandoz is selling, we believe some investors are looking at this as a ...
... that it has entered into an exclusive distribution and commercialization agreement with Sandoz Inc., a division of the Novartis Group, to commercialize Adamis' Symjepi(TM) product ...
... Novartis AG on Thursday said it would sell parts of its Sandoz generic-drugs business in the U.S. in a deal worth up to $1 ...
... Novartis has its U.S. generics sale. After shopping pieces of its troubled Sandoz business for months, the Swiss drugmaker has unloaded a big chunk—including some ...
... organization (CDMO), today announced that it has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada, ...
... will be introduced as US RA treatments in the remainder of 2018, Sandoz's Erelzi (biosimilar to Amgen's branded Enbrel) will likely be the next to ...
... for patients with relapsing forms of multiple sclerosis developed in collaboration with Sandoz In the second quarter of 2018, Momenta recorded $ 11.8 million in ...
Subscribe now for full coverage on Sandoz, Inc.
Start My Free Trial